16 results
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
of such data from such sources.
(xxxix) Cybersecurity. (A) There has been no security breach or incident, unauthorized access or disclosure, or other
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
oversight of data privacy, technology and information security, including cybersecurity and back-up of information systems. Our Nominating and Corporate
S-3
EX-1.2
wb00pbr3m
1 Jul 22
Shelf registration
5:06pm
DEF 14A
uv54puhsdqjk3x87
27 Apr 22
Definitive proxy
5:03pm
10-K
ixf6o rx5
28 Mar 22
Annual report
4:51pm
10-Q
g4l0aircoc2g54bp0jdi
16 Aug 21
Quarterly report
4:51pm
424B4
p7j0k3obt0dw7
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
tbp325r7whm5j6q
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
e0t0sx ap
24 Jun 21
IPO registration (amended)
8:17am
S-1
67w6d19aibkfwsz6in8p
9 Jun 21
IPO registration
5:02pm
DRS/A
qvmbr8nq5
14 May 21
Draft registration statement (amended)
12:00am
DRS
dyox s38mgo8i
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next